furthermore, this study did not adjust for concomitant cigarette smoking
Lieu, C, Yu, G, Kopetz, S , Puhalla, S, Lucas, PC, Sahin, IH, Deming, DA, Philip, PA, Hong, TS, Rojas-Khalil, Y, Loree, JM, Wolmark, N, Yothers, G, George, TJ, Dasari, NV
Cardiovascular Safety The SELECT trial evaluating cardiovascular outcomes in patients with obesity and established cardiovascular disease demonstrated that serious adverse events were actually lower with semaglutide versus placebo (33.4% vs 36.4%), primarily driven by fewer cardiac disorders (11.5% vs 13.5%)
First internally 1st party testing
Furthermore, a meta-analysis reported an improvement in AD severity in patients who received a combination of antioxidants, as demonstrated for oral vitamin D and topical vitamin B12, especially in pediatric patients (123)